While significant progress has been made in the treatment of certain cancers, many cancers including acute myeloid leukemia and brain cancers, remain largely untreatable. We are developing unique small molecule-based synthetic therapies, which are expected to deliver more effective and less toxic therapies aggressive cancers.
Read More